Werewolf Therapeutics, Inc. (HOWL) Misses Q1 EPS by 5c
Tweet
Share
E-mailGet Alerts HOWL Hot Sheet
Join SI Premium – FREE
Werewolf Therapeutics, Inc. (NASDAQ: HOWL) reported Q1 EPS of ($0.39), $0.05 worse than the analyst estimate of ($0.34). Revenue for the quarter came in at $740 thousand versus the consensus estimate of $1.82 million.
For earnings history and earnings-related data on Werewolf Therapeutics, Inc. (HOWL) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Werewolf Therapeutics, Inc. (HOWL) Tops Q2 EPS by 36c
- Bank of the James (BOTJ) Tops Q2 EPS by 71c
- Arbor Realty Trust (ABR) Tops Q2 EPS by 4c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
